Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merck & Co Inc Issues FY 2013 Guidance In Line With Analysts' Estimates


Friday, 1 Feb 2013 07:00am EST 

Merck & Co Inc announced that it expects fiscal 2013 non-GAAP EPS to be between $3.60 and $3.70, and fiscal 2013 GAAP EPS range to be $2.03 to $2.26. The 2013 non-GAAP range excludes acquisition-related costs and costs related to restructuring programs. The Company expects fiscal 2013 revenues to be near fiscal 2012 levels on a constant currency basis. At current exchange rates, sales would be affected unfavorably by approximately 1% to 2% for fiscal 2013. The Company reported revenue of $47.267 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.68 and revenue of $45.611 billion for fiscal 2013. 

Company Quote

59.58
0.6 +1.02%
19 Dec 2014